120157-96-2Relevant articles and documents
A supramolecular oligophenylenevinylene-C60 conjugate
Gutiérrez-Nava, Manuel,Nierengarten, Hélène,Masson, Patrick,Van Dorsselaer, Alain,Nierengarten, Jean-Fran?ois
, p. 3043 - 3046 (2003)
A new methanofullerene derivative with an ammonium subunit has been prepared and its ability to form a supramolecular complex with an oligophenylenevinylene (OPV)-crown ether conjugate evidenced by NMR, electrospray mass spectrometry and luminescence expe
HISTONE DEMETHYLASE INHIBITORS FOR TREATING CANCERS
-
Paragraph 0178-0179, (2021/01/22)
The present disclosure provides a new series of 8-hydroxyquinoline derivatives/analogs that are potent KDM4 inhibitors with high activity and selectivity against KDM4 enzymes. Also disclosed are the pharmaceutical compositions comprising such 8-hydroxyqui
PROCESSES FOR MAKING COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
-
Paragraph 00177, (2013/04/13)
The present invention relates to processes and intermediates for preparing compounds useful as inhibitors of ATR kinase, such as aminopyrazine-isoxazole derivatives and related molecules. The present invention also relates to compounds useful as inhibitors of ATR protein kinase. The invention relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and solid forms of the compounds of this invention. The compounds of this invention have formula (I) or (II) wherein the variables are as defined herein.